NGVT Stock: Price, Earnings History and SEC Filings
Ingevity Corporation (NGVT) last traded at $74.32, down 1.39% on the latest session and up 5.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.74 against an analyst estimate of $1.31, a beat of 32.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NGVT earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 29, 2026 | $1.74 | $1.31 | +32.82% |
| Mar 2026 | May 6, 2026 | $1.15 | $0.84 | +36.90% |
| Dec 2025 | Feb 25, 2026 | $0.58 | $0.74 | -21.62% |
NGVT beat the analyst EPS estimate in 2 of its last 3 reported quarters. Source: Nasdaq.
How NGVT reacts to earnings
Across its last 8 earnings releases, NGVT moved 8.7% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-07-29 | After close | -0.61% |
| 2026-05-06 | After close | -4.88% |
| 2026-02-25 | After close | +1.32% |
| 2025-11-05 | After close | -15.17% |
| 2025-08-04 | After close | +21.32% |
| 2025-05-05 | After close | +10.36% |
| 2025-02-18 | After close | +5.28% |
| 2025-01-16 | Before open | +10.96% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
NGVT financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $1.2B | -$167M | – | -14.3% | $-4.61 |
| 2024 | $1.2B | -$430M | – | -35.9% | $-11.85 |
| 2023 | $1.2B | -$5M | – | -0.4% | $-0.15 |
| 2022 | $1.7B | $212M | – | 12.7% | $5.50 |
| 2021 | $1.4B | $118M | – | 8.5% | $2.95 |
| 2020 | $1.2B | $181M | $270M | 14.9% | $4.37 |
| 2019 | $1.3B | $184M | $161M | 14.2% | $4.35 |
| 2018 | $1.1B | $169M | $158M | 14.9% | $3.97 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for NGVT
- 10-Q · Jul 30, 2026
- 8-K · Jul 29, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 24, 2026Officer or director change, Financial statements and exhibits
- 10-Q · May 7, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- 8-K · May 4, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 8-K · Apr 15, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Mar 30, 2026Material agreement, New financial obligation, Financial statements and exhibits
- DEF 14A · Mar 17, 2026
- 10-K · Feb 26, 2026
Insider filing activity
NGVT insiders filed 6 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
NGVT news
- Ingevity Celebrates 10 Years as a Public Company with NYSE Closing Bell® RingingOct 27, 2026 · finance.yahoo.com
- Sherwin-Williams (SHW) Q3 Earnings Miss EstimatesOct 27, 2026 · finance.yahoo.com
- NYSE Publishes 'The Busiest Room on Wall Street': NYSE Content UpdateOct 26, 2026 · finance.yahoo.com
- Orion Launches PRINTEX Chroma 450 BEADS for Engineered PlasticsOct 20, 2026 · finance.yahoo.com
About Ingevity Corporation
Ingevity Corporation (NGVT) is a US-listed public company on NYSE. The SEC classifies its business as Chemicals & Allied Products. It is incorporated in DE. Its fiscal year ends in December.